Silmedic Sp. z o.o.

Katowice, Poland
Medical clinic in Katowice
gen, Sikorskiego 30/lok u 70, 40-282 Katowice

About Silmedic Sp. z o.o.


"Silmedic sp. z o.o. realizuje programy leczenia umożliwiające pacjentom dostęp do bezpłatnych, innowacyjnych metod leczenia niedostępnych na Polskim rynku. Programy te, prowadzone są przez wykwalifikowany zespół specjalistów różnych dziedzin medycyny z wieloletnim doświadczeniem. Przestrzegamy wszelkich zasad dobrej praktyki lekarskiej oraz przepisów prawa polskiego. Udział w badaniu klinicznym niesie za sobą wiele korzyści dla pacjenta : • Bezpłatna opieka wykwalifikowanych specjalistów różnych dziedzin • Dokładne monitorowanie stanu zdrowia przez cały okres leczenia • Stały i szybki kontakt ze specjalistą • Nieodpłatny dostęp do innowacyjnej metody leczenia • Możliwość nieodpłatnego wykonania szerokiego zakresu badań zleconych przez"
  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials
ACADIA Pharmaceuticals Inc.
1
Allergan
1
Aziende Chimiche Riunite Angelini Francesco S.p.A
1
Bristol-Myers Squibb
1
Celgene
1
EMD Serono Research & Development Institute, Inc.
1
Galapagos NV
1
H. Lundbeck A/S
1
Integrative Research Laboratories AB
1
Pfizer
1
Suven Life Sciences Limited
1
Total Rows: 12

Clinical Trials at Silmedic Sp. z o.o.


During the past decade, Silmedic Sp. z o.o. conducted 12 clinical trials. In the 10-year time frame, 12 clinical trials started and 5 clinical trials were completed, i.e. on average, 41.7% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 4 clinical trials were completed. i.e. 100% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 Years443311002222000011111122Started TrialsCompleted Trails2017201820192020202120220246
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Trazodone in Painful Diabetic Neuropathy
2017-05-16
2018-08-09
Completed
142
Phase IIb Study of Evobrutinib in Subjects With Rheumatoid Arthritis
2017-09-18
2019-09-23
Completed
390
An Investigational Study to Evaluate BMS-986165 in Participants With Systemic Lupus Erythematosus
2017-09-21
2021-10-28
Completed
363
Dose Ranging Study of RPL554 in Chronic Obstructive Pulmonary Disease (COPD) Patients
2017-06-01
2018-02-07
Completed
405
A Study of Crisaborole Ointment 2%; Crisaborole Vehicle; TCS and TCI in Subjects Aged ≥ 2 Years, With Mild-moderate AD
2018-04-27
2020-12-11
Terminated
237
A Safety Study of Pimavanserin in Adult and Elderly Subjects Experiencing Neuropsychiatric Symptoms Related to Neurodegenerative Disease
2018-05-21
2022-05-06
Completed
784
Diabetic Gastroparesis Study 05
2018-12-20
2020-10-05
Terminated
202
Study to Evaluate the Effect of Filgotinib on Semen Parameters in Adult Males With Active Rheumatoid Arthritis, Psoriatic Arthritis, Ankylosing Spondylitis, or Non-radiographic Axial Spondyloarthritis
2019-05-28
2024-10-01
Active, not recruiting
109

Rows per page:

1–12 of 12

Clinical Trials Sponsors and Collaborators


Out of the total clinical trials conducted in "Silmedic Sp. z o.o." #1 sponsor was "ACADIA Pharmaceuticals Inc." with 1 trials, followed by "Allergan" with 1 trials sponsored, "Aziende Chimiche Riunite Angelini Francesco S.p.A" with 1 trials sponsored, "Bristol-Myers Squibb" with 1 trials sponsored and "Celgene" with 1 trials sponsored. Other sponsors include 2 different institutions and companies that sponsored additional 12 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Silmedic Sp. z o.o." #1 collaborator was "Chiltern International Inc." with 1 trials as a collaborator, "Gilead Sciences" with 1 trials as a collaborator and "Merck KGaA, Darmstadt, Germany" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.
Created with Highcharts 11.1.0Top Leading SponsorsACADIA Pharmaceuticals Inc.: 1ACADIA Pharmaceuticals Inc.: 1Allergan: 1Allergan: 1Aziende ChimicheRiunite AngeliniFrancesco S.p.A: 1Aziende ChimicheRiunite AngeliniFrancesco S.p.A: 1Bristol-Myers Squibb: 1Bristol-Myers Squibb: 1Celgene: 1Celgene: 1EMD Serono Research &Development Institute,Inc.: 1EMD Serono Research &Development Institute,Inc.: 1Galapagos NV: 1Galapagos NV: 1H. Lundbeck A/S: 1H. Lundbeck A/S: 1Integrative ResearchLaboratories AB: 1Integrative ResearchLaboratories AB: 1Pfizer: 1Pfizer: 1

Created with Highcharts 11.1.0Top CollaboratorsChiltern International Inc.: 1Chiltern International Inc.: 1Gilead Sciences: 1Gilead Sciences: 1Merck KGaA,Darmstadt, Germany: 1Merck KGaA,Darmstadt, Germany: 1

Clinical Trials Conditions at Silmedic Sp. z o.o.


According to Clinical.Site data, the most researched conditions in "Silmedic Sp. z o.o." are "Rheumatoid Arthritis" (2 trials), "Agitation" (1 trials), "Alzheimer's Type Dementia" (1 trials), "Ankylosing Spondylitis" (1 trials) and "Atopic Dermatitis" (1 trials). Many other conditions were trialed in "Silmedic Sp. z o.o." in a lesser frequency.

Clinical Trials Intervention Types at Silmedic Sp. z o.o.


Most popular intervention types in "Silmedic Sp. z o.o." are "Drug" (12 trials) and "Other" (2 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (10 trials), "BMS-986165" (1 trials), "CC-99677" (1 trials), "Crisaborole Vehicle" (1 trials) and "Crisaborole ointment, 2%" (1 trials). Other intervention names were less common.

Clinical Trials Genders at Silmedic Sp. z o.o.


The vast majority of trials in "Silmedic Sp. z o.o." are 11 trials for "All" genders and 1 trials for "Male" genders.

Clinical Trials Status at Silmedic Sp. z o.o.


Currently, there are NaN active trials in "Silmedic Sp. z o.o.". undefined are not yet recruiting, 2 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 6 completed trials in Silmedic Sp. z o.o., undefined suspended trials, and 3 terminated clinical trials to date.
Out of the total trials that were conducted in Silmedic Sp. z o.o., 0 "Phase 1" clinical trials were conducted, 8 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By PhasePhase 2: 8Phase 2: 8Phase 3: 3Phase 3: 3Phase 4: 1Phase 4: 1

Created with Highcharts 11.1.0Trials StatusCompleted: 6Completed: 6Terminated: 3Terminated: 3Recruiting: 2Recruiting: 2Active, not recruiting: 1Active, not recruiting: 1